Sign In
or Login with
Check this out! We've a new feature you should know about. Click here!
Just a heads Up! 3 new Users are now following you!
Oops... portfolio named 'My Portfolio' already exists. Try a different name!
Woah... Successfully created portfolio 'Smart Investments' !

MESSAGES

Platinum Member
1390 Followers

The pharma major has entered into a partnership with Bayer to market and distribute a second brand of Vericiguat in India. Under the terms of this agreement, Bayer has granted non-exclusive rights to Dr. Reddys under the brand name Gantra. Vericiguat is used in the treatment of chronic heart failure with a reduced ejection fraction.

40 days 11 hrs 36 min 13 sec   |  Track
  I agree to the M3 code of conduct
No Replies
Explore Topics

MARKET VIEW

OUTLOOK

SECTORS

STRATEGY

VIEW

PERSONAL FINANCE

INSURANCE

INVEST

MUTUAL FUND

Login or Sign up now!
DID YOU KNOW?